Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8383114 Pharmaceutical formulations

Patent 8383114 was granted and assigned to Amgen on February, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 22 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 22 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11986526 Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)
0
Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11890322 Methods for promoting wound healing and hair growth comprising GDNF administration
0
Edits on 29 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 29 Nov, 2023
Edits made to:
Article (+173 characters)
Article

Patent abstract

A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Edits on 12 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11696951 Viscosity-reducing compounds for protein formulations
0
Edits on 14 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11672865 Viscosity-reducing excipient compounds for protein formulations
0
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11660343 Viscosity-reducing excipient compounds for protein formulations
0
Edits on 19 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08383114 Pharmaceutical formulations US Patent 8383114 Pharmaceutical formulations

Infobox
Patent Number
0838311400
Patent Number
838311400
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
083831140
Date of Patent
February 26, 2013
0
Patent Application Number
126801280
Date Filed
September 29, 2008
0
Patent Primary Examiner
‌
Yunsoo Kim
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
083831140
Date of Patent
February 26, 2013
0
Patent Application Number
126801280
Date Filed
September 29, 2008
0
Patent Primary Examiner
‌
Yunsoo Kim
0
Edits on 16 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 16 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08383114 Pharmaceutical formulations

Infobox
Is a
Patent
Patent
Current assignee
Amgen
Amgen
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08383114
Date of patent
February 26, 2013
Patent application number
12680128
Date Filed
September 29, 2008
Patent primary examiner
‌
Yunsoo Kim

Find more entities like US Patent 8383114 Pharmaceutical formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo